Insufficient scRNA-seq data for expression of NUDT11 at single-cell level.
Insufficient scRNA-seq data for expression of NUDT11 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 639.74 | 243 / 245 | 98% | 37.28 | 490 / 502 |
brain | 96% | 1445.96 | 2545 / 2642 | 100% | 61.97 | 702 / 705 |
uterus | 99% | 407.20 | 168 / 170 | 39% | 8.54 | 178 / 459 |
adrenal gland | 46% | 115.20 | 118 / 258 | 74% | 15.43 | 170 / 230 |
ovary | 100% | 828.00 | 180 / 180 | 14% | 1.50 | 59 / 430 |
pancreas | 91% | 292.83 | 299 / 328 | 21% | 1.60 | 38 / 178 |
blood vessel | 95% | 275.70 | 1266 / 1335 | 0% | 0 | 0 / 0 |
bladder | 81% | 204.71 | 17 / 21 | 13% | 2.09 | 68 / 504 |
skin | 64% | 314.83 | 1152 / 1809 | 24% | 3.11 | 113 / 472 |
esophagus | 49% | 92.68 | 710 / 1445 | 37% | 6.56 | 68 / 183 |
intestine | 67% | 206.36 | 643 / 966 | 5% | 0.38 | 26 / 527 |
breast | 49% | 87.93 | 223 / 459 | 22% | 2.34 | 245 / 1118 |
thymus | 11% | 17.06 | 74 / 653 | 47% | 7.10 | 287 / 605 |
tonsil | 0% | 0 | 0 / 0 | 58% | 9.88 | 26 / 45 |
lung | 6% | 9.92 | 37 / 578 | 32% | 5.83 | 373 / 1155 |
adipose | 39% | 69.91 | 464 / 1204 | 0% | 0 | 0 / 0 |
stomach | 31% | 81.47 | 112 / 359 | 5% | 0.47 | 14 / 286 |
eye | 0% | 0 | 0 / 0 | 14% | 0.89 | 11 / 80 |
kidney | 9% | 13.37 | 8 / 89 | 4% | 0.53 | 34 / 901 |
liver | 0% | 0.70 | 1 / 226 | 4% | 0.58 | 18 / 406 |
spleen | 2% | 2.67 | 4 / 241 | 0% | 0 | 0 / 0 |
heart | 1% | 1.10 | 7 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 1.23 | 7 / 929 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.28 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071543 | Biological process | diphosphoinositol polyphosphate metabolic process |
GO_1901909 | Biological process | diadenosine hexaphosphate catabolic process |
GO_1901911 | Biological process | adenosine 5'-(hexahydrogen pentaphosphate) catabolic process |
GO_1901907 | Biological process | diadenosine pentaphosphate catabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0034432 | Molecular function | bis(5'-adenosyl)-pentaphosphatase activity |
GO_0000298 | Molecular function | endopolyphosphatase activity |
GO_0008486 | Molecular function | diphosphoinositol-polyphosphate diphosphatase activity |
GO_0034431 | Molecular function | bis(5'-adenosyl)-hexaphosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | NUDT11 |
Protein name | Diphosphoinositol polyphosphate phosphohydrolase 3-beta (DIPP-3-beta) (DIPP3-beta) (hDIPP3beta) (EC 3.6.1.52) (Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 3-beta) (Diadenosine hexaphosphate hydrolase (AMP-forming)) (EC 3.6.1.60) (Nucleoside diphosphate-linked moiety X motif 11) (Nudix motif 11) (hAps1) |
Synonyms | APS1 DIPP3B |
Description | FUNCTION: Cleaves a beta-phosphate from the diphosphate groups in PP-InsP5 (diphosphoinositol pentakisphosphate), suggesting that it may play a role in signal transduction. Also able to catalyze the hydrolysis of dinucleoside oligophosphates, with Ap6A and Ap5A being the preferred substrates. The major reaction products are ADP and p4a from Ap6A and ADP and ATP from Ap5A. Also able to hydrolyze 5-phosphoribose 1-diphosphate. . |
Accessions | ENST00000375992.4 Q96G61 |